Equillium (EQ) Other Working Capital Changes (2022)

Equillium (EQ) posted quarterly Other Working Capital Changes of -$69000.0 for Q1 2022.

Equillium (EQ) Other Working Capital Changes (2022) Analysis & Trends

Equillium (EQ) has reported Other Working Capital Changes for 9 consecutive years, with $192000.0 the latest figure, recorded in Q1 2026.

In Q1 2026, Other Working Capital Changes rose 163.37% year-over-year to $192000.0; the TTM figure through Mar 2026 stood at -$768000.0 (down 265.71% YoY), while the FY2025 annual figure was -$1.3 million, up 44.48% from the prior year.
Other Working Capital Changes was little changed at -$69000.0 in Q1 2022 per EQ's latest filing.
Across five years, Other Working Capital Changes topped out at $8.6 million in Q4 2023 and bottomed at -$4.9 million in Q2 2024.
Historically, Other Working Capital Changes has averaged -$81352.9 across 5 years, with a median of -$303000.0 in 2025.
On a YoY basis, Other Working Capital Changes climbed as much as 1319.57% in 2023 and fell as far as 654.35% in 2023.
Equillium's Other Working Capital Changes stood at $608000.0 in 2022, then soared by 1319.57% to $8.6 million in 2023, then sank by 103.21% to -$277000.0 in 2024, then surged by 215.88% to $321000.0 in 2025, then tumbled by 40.19% to $192000.0 in 2026.
Business Quant data shows EQ's Other Working Capital Changes at $192000.0 in Q1 2026, $321000.0 in Q4 2025, and -$8000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Equillium	263.86 Mn	263.86 Mn	-

Download Data